Study of Apatinib Combined With TACE in Advance Hepatocellular Carcinoma
Latest Information Update: 05 Nov 2021
Price :
$35 *
At a glance
- Drugs Rivoceranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 15 Jan 2018 New trial record
Latest Information Update: 05 Nov 2021